Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance
暂无分享,去创建一个
C. Paweletz | P. Jänne | J. Köhler | P. Kirschmeier | P. Gokhale | Y. Kuang | F. Hong | Luke J. Taus | Magda Bahcall | K. Dholakia | Zihan Wei | Sujuan Guo | Stephen Wang | Nam-Doo Kim | C. Lau | T. Sim | Pratik R Chopade | Jiannan Guo | Jiannan Guo